chemotherapy

Radiotherapy for the management of renal medullary carcinoma

By Sharon Deveson Kell|2024-03-08T15:11:05+00:008 Mar 2024|Drug treatments|

Renal medullary carcinoma (RMC) is a rare and aggressive cancer [...]

Comments Off

Treatment of rare subtypes of kidney cancer

By Robert|2022-11-09T09:50:57+00:007 Nov 2022|Uncategorized|

At the International Kidney Cancer Symposium (IKCS) in North America [...]

Comments Off

Efficacy and safety of gemcitabine plus doxorubicin in patients with renal medullary carcinoma (RMC)

By Sharon Deveson Kell|2021-10-19T07:58:09+00:0019 Oct 2021|Subtypes of RCC|

Renal medullary carcinoma (RMC) is an extremely rare and aggressive [...]

Comments Off

NHS England spotlight on specialised services – a new report

By Sharon Kell|2017-09-18T09:06:09+00:0018 Sep 2017|Cancer news|

A new report from NHS England, Spotlight on specialised services, provides [...]

Comments Off

Management of renal medullary carcinoma

By Sharon Kell|2017-05-10T16:02:57+00:0010 May 2017|Drug treatments, Subtypes of RCC|

Renal medullary carcinoma is a very rare subtype of renal [...]

Comments Off

Address

Action Kidney Cancer

11th Floor
3 Piccadilly Place
Manchester M1 3BN

Helpline

0800 121 8721
Email Us

About Action Kidney Cancer

We are the UK’s largest and most active patient-led kidney cancer charity. Whether you are a patient, survivor or someone you know has been diagnosed with kidney cancer, you have come to the right place to find support and information, and to be part of a caring and knowledgeable community of people: We are here to help you.

Registered charity in England, Wales (1164238), and Scotland (SC051330).

© Copyright Action Kidney Cancer 2021

Links

Branding by Kingswood Marketing

Policies

Website Policies

Complaints Policy

Equal Opportunities Policy

Information Governance Policy

Social Media Policy

Health Information Policy

Follow

Our Website Design Specialist | Douglass Digital

Helpline: 0800 121 8721

support@actionkidneycancer.org